Cargando…
Contribution of markers of adiposopathy and adipose cell size in predicting insulin resistance in women of varying age and adiposity
Adipose tissue (AT) dysfunctions, such as adipocyte hypertrophy, macrophage infiltration and secretory adiposopathy (low plasma adiponectin/leptin, A/L, ratio), associate with metabolic disorders. However, no study has compared the relative contribution of these markers to cardiometabolic risk in wo...
Autores principales: | Tremblay, Eve-Julie, Tchernof, André, Pelletier, Mélissa, Chabot, Nicolas, Joanisse, Denis R., Mauriège, Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037496/ https://www.ncbi.nlm.nih.gov/pubmed/35436409 http://dx.doi.org/10.1080/21623945.2022.2059902 |
Ejemplares similares
-
Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction
por: Bays, Harold
Publicado: (2014) -
The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?
por: Bini, Simone, et al.
Publicado: (2021) -
Is adiposopathy (sick fat) an endocrine disease?
por: Bays, H E, et al.
Publicado: (2008) -
Obesity, adiposopathy, and quantitative imaging
biomarkers
por: Yamauchi, Fernando Ide, et al.
Publicado: (2017) -
Ischemic Preconditioning Enhances Aerobic Adaptations to Sprint-Interval Training in Athletes Without Altering Systemic Hypoxic Signaling and Immune Function
por: Paradis-Deschênes, Pénélope, et al.
Publicado: (2020)